Search
for
Sort by
Research 541–570 of 1000+
- Clinical Case Notes. Retinoblastoma, microphthalmia and the chromosome 13q deletion syndrome
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- The PDGF/PDGFR pathway as a drug target
- A Murine Model for Inducing and Manipulating Hair Follicle Regression (Catagen): Effects of Dexamethasone and Cyclosporin A
- Drug-Induced Skin, Nail and Hair Disorders
- Toxic Epidermal Necrolysis
- Nanotechnology in Dermatology
- Female Pattern Hair Loss
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Alopecia With Endocrine Therapies in Patients With Cancer
- Endocrine-skin interactions
- Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6
- Novel cosmeceuticals from plants—An industry guided review
- Polyamines and hair: a couple in search of perfection
- Prescribing testosterone and DHEA: The role of androgens in women
- Recent Formulation Advances of Mangiferin
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Topical use of systemic drugs in dermatology: A comprehensive review
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Potential Medical Uses of Cannabigerol: A Brief Overview
- The concealed side of caspases: beyond a killer of cells
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Cystine-thiamin-containing hair-growth formulation modulates the response to UV radiation in an in vitro model for growth-limiting conditions of human keratinocytes
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Hypertrichosis of the pinnae in a patient using panitumumab
- Interpretation of Laboratory Data and General Physical Examination by Pharmacists